MRManuel Ramirez-Trejo

Manuel Ramirez-Trejo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manuel Ramirez-Trejo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Are reporting guidelines used in infectious diseases publications? An analysis of more than 1,000 articles

    by Aldo Barajas-Ochoa, Manuel Ramirez-Trejo, Aditee Dash, Jillian E. Raybould, Gonzalo Bearman

    Objective:To assess whether 16 reporting guidelines of Enhancing the QUAlity and Transparency Of Health Research (EQUATOR) were used in infectious diseases research publications.Design:This cross-sectional, audit-type study assessed articles published in five infectious diseases journals in 2019.Methods:All articles were manually reviewed to assess if a reporting guideline was advisable and searched for the names and acronyms of 16 reporting guidelines. An “advisable use rate” was calculated.Results:We reviewed 1,251 manuscripts across five infectious diseases journals. Guideline use was advisable for 973 (75%) articles. Reporting guidelines were used in 85 articles, 6.1% of total articles, and 8% (95% CI 6%–9%) of articles for which guidelines were advised. The advisable use rate ranged from 0.06 to 0.17 for any guideline, 0–0.08 for CONSORT, 0.53–1 for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), and 0–0.66 for Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) : The TRIPOD statement. No trends were observed across the five journals.Conclusions:The use of EQUATOR-related reporting guidelines is infrequent, despite journals and publishers promoting their usage. Whether this finding is attributable to knowledge, acceptance, or perceived usefulness of the guidelines still needs to be clarified.


  • Gender representation in rheumatology journals: an assessment of editors, editorial boards, and authors

    by Aldo Barajas-Ochoa, Ingris Peláez-Ballestas, Manuel Ramirez-Trejo, Paloma Gradilla-Magaña, Antonio Cisneros-Barrios, Amaranta Manrique de Lara, Alfonso Gastelum-Strozzi, Cesar Ramos-Remus

    Diversity is widely recognized as a driver of excellence and innovation. In recent years, women have become an increasingly significant part of the rheumatology workforce. We aimed to assess the gender representation of the leading rheumatology journals' editors and to explore whether editors' gender correlates with the gender of the first and last authors of published articles. We conducted a cross-sectional study and extracted editorial members of rheumatology journals in quartiles 1 to 3 (Clarivate Analytics) from each journal's website. We categorized editorial positions according to the level of influence in manuscript acceptance decision-making (levels I to III). The gender of editors and of the first and last authors in all 2019 original articles published in a sample of 15 rheumatology journals was assigned using a combination of digital gallery and manual searches. There were 2242 editors' names retrieved from 43 journals, 24 (26%) of the 94 editors at level I, 139 (36%) of 385 editors at level II, and 469 (27%) of 1763 at level III were female. The imbalance between journals was heterogeneous. Females were the first authors in 1342 (48%) and the last authors in 969 (35%) of the 2797 published articles. However, we found no significant correlation between editors' and authors' gender. Our data showed uneven gender representation on the editorial boards of most rheumatology journals, but we did not find any apparent vertical segregation or influence on publishing by gender. Our findings suggest that a generational transition may be occurring among authors.


  • Open Access

    The Use of Reporting Guidelines in Rheumatology: A Cross-Sectional Study of Over 850 Manuscripts Published in 5 Major Rheumatology Journals

    by Aldo Barajas-Ochoa, Antonio Cisneros-Barrios, Manuel Ramirez-Trejo, Cesar Ramos-Remus

    Objective: To assess whether 16 of the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network–related reporting guidelines were used in rheumatology publications.Methods: This was a cross-sectional study of research articles published in 5 high-performance rheumatology-focused journals in 2019. All articles were (1) manually reviewed to assess whether the use of a reporting guideline could be advisable, and (2) searched for the names and acronyms (eg, CONSORT [Consolidated Standards of Reporting Trials], STROBE [Strengthening the Reporting of Observational Studies in Epidemiology]) of 16 reporting guidelines. To calculate the “advisable use rate,” the number of articles for which a guideline was used was divided by the number of articles for which the guideline was advised. Descriptive statistics were used.Results: We reviewed 895 manuscripts across the 5 journals. The use of a guideline was deemed advisable for 693 (77%) articles. Reporting guidelines were used in 50 articles, representing 5.6% of total articles and 7.2% (95% CI 5-9) of articles for which guidelines were advised. The advisable use rate boundaries within which a guideline was applied by the journals were 0.03 to 0.10 for any guideline, 0 to 0.26 for CONSORT, 0.01 to 0.07 for STROBE, 0 to 0.8 for Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), and 0 to 0.14 for Animal Research: Reporting of In Vivo Experiments (ARRIVE). No identifiable trends in the variables studied were observed across the 5 journals.Conclusion: The limited use of reporting guidelines appears counterintuitive, considering that guidelines are promoted by journals and are intended to help authors report relevant information. Whether this finding is attributable to issues with the diffusion, awareness, acceptance, or perceived usefulness of the guidelines remains to be clarified.